© 2020 MJH Life Sciences and OncLive. All rights reserved.
August 17, 2017
Moshe Ornstein, MD, staff, Cleveland Clinic, discusses the challenges surrounding immunotherapy for patients with renal cell carcinoma.
July 24, 2017
Moshe Ornstein, MD, staff, Cleveland Clinic, discusses the role of interleukin-2 (IL-2) going forward in patients with renal cell carcinoma (RCC).
September 10, 2015
As you begin your first year of oncology fellowship, I want to share with you a few things
Iâ€™ve learned since standing in your shoes just 12 months ago.